Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07569211
Simplified HCV Integrated Management Model in Methadone Clinics in UkraineThe Western-Eastern European Partnership Initiative on HIV, Viral Hepatitis and TBCompletedNot Applicable
NCT07569211Completed
Not Applicable
Simplified HCV Integrated Management Model in Methadone Clinics in UkraineThe Western-Eastern Europ...
NCT07570927
Salivary Microbiota and Antimicrobial Resistance in Relation to Chlorhexidine UseMasaryk UniversityCompletedNot Applicable
NCT07570927Completed
Not Applicable
Salivary Microbiota and Antimicrobial Resistance in Relation to Chlorhexidine Us...Masaryk University
NCT07569471
REFLECT: A Novel Group-Based Compassion-Focussed Cognitive Behavioural Approach to Core Beliefs in PsychosisUniversity of TorontoRecruitingNot Applicable
NCT07569471Recruiting
Not Applicable
REFLECT: A Novel Group-Based Compassion-Focussed Cognitive Behavioural Approach...University of Toronto
NCT07569614
Comparative Effects of Remimazolam Tosylate and Dexmedetomidine on Postoperative Delirium in Elderly Patients Undergoing Thoracoscopic Surgery.First Affiliated Hospital of Kunming Medical UniversityCompletedNot Applicable
NCT07569614Completed
Not Applicable
Comparative Effects of Remimazolam Tosylate and Dexmedetomidine on Postoperative...First Affiliated Hospital...
NCT07569536
Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic ShockCentre Hospitalier Universitaire DijonNot Yet RecruitingPhase 3
NCT07569536Not Yet Recruiting
Phase 3
Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in...Centre Hospitalier Univer...
NCT07570667
Global Longitudinal Health Monitoring and Blood Sample Collection Study to Promote Early-stage Disease Detection and Personalized/Precision Care Using Innovative Research PlatformsCenter for Molecular Fingerprinting Research Nonprofit LLCNot Yet Recruiting
NCT07570667Not Yet Recruiting
—
Global Longitudinal Health Monitoring and Blood Sample Collection Study to Promo...Center for Molecular Fing...
NCT07571070
High-Intensity Intermittent Training and Sport-Specific Performance in Youth Amateur BoxersFederal University of VicosaCompletedNot Applicable
NCT07571070Completed
Not Applicable
High-Intensity Intermittent Training and Sport-Specific Performance in Youth Ama...Federal University of Vic...
NCT07571369
Stress Modulation and Dynamic BalanceKafrelsheikh UniversityNot Yet RecruitingNot Applicable
NCT07571369Not Yet Recruiting
Not Applicable
Stress Modulation and Dynamic BalanceKafrelsheikh University
NCT07571551
Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell CarcinomaJinling Hospital, ChinaNot Yet RecruitingPhase 2
NCT07571551Not Yet Recruiting
Phase 2
Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell CarcinomaJinling Hospital, China
NCT07569757
Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple MyelomaChia Tai Tianqing Pharmaceutical Group Co., Ltd.Not Yet RecruitingPhase 3
NCT07569757Not Yet Recruiting
Phase 3
Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple MyelomaChia Tai Tianqing Pharmac...
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07570017
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaGuangzhou Lupeng Pharmaceutical Company LTD.Not Yet RecruitingPhase 1
NCT07570017Not Yet Recruiting
Phase 1
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refrac...Guangzhou Lupeng Pharmace...
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07569692
(PREventive Invasive Strategy for Obstructive Coronary Artery Disease With Vulnerable Plaque Evaluated by CoroNary Computed Tomography Angiography)-2CardioVascular Research Foundation, KoreaNot Yet RecruitingNot Applicable
NCT07569692Not Yet Recruiting
Not Applicable
(PREventive Invasive Strategy for Obstructive Coronary Artery Disease With Vulne...CardioVascular Research F...
NCT07571928
A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive AzoospermiaMartin Blomberg JensenNot Yet RecruitingPhase 1
NCT07571928Not Yet Recruiting
Phase 1
A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoo...Martin Blomberg Jensen
NCT07568808
Core Stabilization and Kinesthetic Training in Diplegic CPUniversity of LahoreCompletedNot Applicable
NCT07568808Completed
Not Applicable
Core Stabilization and Kinesthetic Training in Diplegic CPUniversity of Lahore
NCT07569081
A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) SyndromeGlaxoSmithKlineNot Yet RecruitingPhase 2
NCT07569081Not Yet Recruiting
Phase 2
A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With V...GlaxoSmithKline
NCT07569731
Fibrous Dysplasia: An Epidemiological and Correlational Study of Multimodal DataIstituto Ortopedico RizzoliRecruiting
NCT07569731Recruiting
—
Fibrous Dysplasia: An Epidemiological and Correlational Study of Multimodal DataIstituto Ortopedico Rizzo...
NCT07571837
Modulation of Periapical Inflammation Following Nano-sized Intracanal Medication. A Randomized Controlled Clinical TrialAl-Azhar UniversityRecruitingNot Applicable
NCT07571837Recruiting
Not Applicable
Modulation of Periapical Inflammation Following Nano-sized Intracanal Medication...Al-Azhar University
Result Breakdown
Not yet recruiting9 (45%)
Completed5 (25%)
Recruiting5 (25%)
Active, not recruiting1 (5%)
not_applicable10 (50%)
Not Specified3 (15%)
Phase 23 (15%)
Phase 32 (10%)
Phase 12 (10%)